6 Coagulation Disorders
A practical guide to coagulation-factor disorders, their assessment and testing, and nursing priorities for urgent bleeding care, prevention, treatment, and patient education.
How affect bleeding
interfere with the formation or stability of a fibrin clot. Bleeding may continue longer than expected after an injury or procedure, occur spontaneously, or affect muscles, joints, or internal sites. Inherited disorders include , , and ; acquired factor deficiencies or inhibitors can produce similar bleeding and also require prompt evaluation.
and B
results from deficient or dysfunctional , while results from deficient or dysfunctional . Both are usually inherited in an X-linked pattern, but people of any sex may have low factor levels and clinically important bleeding.
Severity is based on baseline factor activity:
Severe: less than .
Moderate: –.
Mild: greater than but less than .
Bleeding may occur in joints or muscles, or internally. Joint bleeding, also called , may begin with warmth, tingling, or tightness, followed by pain, swelling, and reduced movement. A person with mild hemophilia may first become aware of the disorder after surgery, dental work, or a significant injury.
Von Willebrand disease
helps platelets adhere at an injured vessel and carries in the blood. Because of these roles, can affect both initial platelet-plug formation and activity.
VWD commonly causes mucocutaneous bleeding, including recurrent nosebleeds, easy bruising, prolonged bleeding from cuts or dental work, heavy menstrual bleeding, and postpartum bleeding. Severe VWD can also cause joint or internal bleeding.
VWD is classified as type 1, with reduced ; type 2, with dysfunctional and subtypes; or type 3, with very little or no . Treatment depends on the type, the bleeding episode, and the individual’s response. Options may include desmopressin for selected patients, -containing concentrate, and antifibrinolytic medicines such as tranexamic acid. Desmopressin is generally contraindicated in type 2B and ineffective in type 3. When desmopressin is used, follow fluid-restriction and monitoring instructions because of the risk of hyponatremia.
History and physical assessment
Take a focused bleeding history and assess whether bleeding is happening now. Ask about the site, onset, amount, duration, recurrence, and triggers of bleeding, and whether it stops with usual pressure. Ask about nose or gum bleeding, easy bruising, prolonged bleeding after minor injury, surgery, dental work, or childbirth; joint or muscle pain and swelling; blood in urine or stool; and menstrual bleeding or anemia.
Clarify personal and family history of bleeding disorders, prior diagnoses, factor treatments and response to treatment, and possible factor inhibitors. Review prescription and nonprescription medicines, especially aspirin, NSAIDs, anticoagulants, and antiplatelet drugs.
Examine skin and mucous membranes for bruises or active bleeding. Assess joints and muscles for warmth, swelling, pain, range of motion, and neurovascular changes. Check vital signs and for blood-loss symptoms such as pallor, dizziness, weakness, tachycardia, and hypotension. Significant bleeding can be present before vital signs change.
Laboratory evaluation
Initial tests often include a CBC with platelet count, PT/INR, aPTT, and fibrinogen. Hemophilia typically causes an isolated prolonged aPTT, but screening tests can be normal in mild hemophilia or VWD.
Confirm suspected hemophilia with specific or activity assays. VWD evaluation includes antigen, activity, and activity; repeat or specialized testing may be needed. A normal PT or aPTT does not rule out VWD.
Recognize life-threatening bleeding
Treat suspected intracranial, neck or throat, chest, abdominal, gastrointestinal, or major muscle bleeding as an emergency. Warning signs include head injury or severe headache, altered mental status, vomiting, new weakness, trouble breathing or swallowing, severe abdominal or back pain, blood in vomit or stool, and rapidly expanding swelling.
Activate the emergency response and notify the treating hematology team. Follow the patient’s emergency plan and give prescribed hemostatic treatment promptly. When a serious bleed is suspected, do not delay urgent treatment solely to obtain imaging or laboratory results.
Manage joint and muscle bleeding
Promptly report new pain, warmth, tightness, swelling, or reduced movement. An early joint or muscle bleed may have little visible swelling. Follow the individualized plan for factor or other prescribed hemostatic treatment, analgesia, and protection of the affected area. For an acute joint or muscle bleed, immobilization, compression, or splinting may be used when appropriate and directed by the care plan.
Reassess pain, swelling, movement, and distal circulation, sensation, and function. Increasing pain, numbness, weakness, or poor distal perfusion may indicate compartment syndrome and needs emergency evaluation.
Reduce preventable bleeding
Reduce avoidable bleeding and trauma while coordinating care with the hematology team:
Avoid unnecessary venipunctures and invasive procedures. Coordinate required procedures with the hematology team. After a required blood draw or injection, apply firm, sustained pressure and check for continued bleeding or hematoma.
Avoid intramuscular injections when possible, as well as rectal temperatures or suppositories. Use a soft toothbrush and an electric razor when appropriate.
Do not give aspirin or NSAIDs unless specifically prescribed after risk review. Check before starting medicines or supplements that may increase bleeding.
Use fall- and injury-prevention measures while supporting safe activity as advised by the care team.
Support treatment and monitoring
Hemophilia treatment may include replacement or IX, prophylaxis to prevent bleeds, or other disorder-specific therapies. VWD treatment is selected according to type and clinical situation. Verify the prescribed product, dose, route, timing, and response. Document the bleeding site and symptoms, interventions, and reassessment.
Monitor for ongoing blood loss, anemia, adverse effects, and, when relevant, development of factor inhibitors or treatment complications. Refer to or coordinate care with a hemophilia treatment center or hematology service.
Teach patients and families
Reinforce the written emergency plan, how and when to contact the hematology team, and when to seek emergency care. Encourage medical identification and communication of the disorder before procedures or dental care.
Explain that new or unexplained severe pain, head injury, unusual bleeding, or bleeding that does not stop requires urgent attention, even if the person initially feels well.